These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 32435867)

  • 21. Commentary: COVID-19 in patients with diabetes.
    Hill MA; Mantzoros C; Sowers JR
    Metabolism; 2020 Jun; 107():154217. PubMed ID: 32220611
    [No Abstract]   [Full Text] [Related]  

  • 22. Recommendations and management of hyperglycaemia in pregnancy during COVID-19 pandemic in Italy.
    Torlone E; Sculli MA; Bonomo M; Di Benedetto A; Di Cianni G; Festa C; Formoso G; Lapolla A; Mannino D; Napoli A; Scavini M; Succurro E; Vitacolonna E; Sciacca L
    Diabetes Res Clin Pract; 2020 Aug; 166():108345. PubMed ID: 32710999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of COVID-19 on people with diabetes.
    Bellido V; Pérez A
    Endocrinol Diabetes Nutr (Engl Ed); 2020; 67(6):355-356. PubMed ID: 32475769
    [No Abstract]   [Full Text] [Related]  

  • 24. Managing Diabetes in Pregnancy Before, During, and After COVID-19.
    Murphy HR
    Diabetes Technol Ther; 2020 Jun; 22(6):454-461. PubMed ID: 32396397
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical considerations for patients with diabetes in times of COVID-19 epidemic.
    Gupta R; Ghosh A; Singh AK; Misra A
    Diabetes Metab Syndr; 2020; 14(3):211-212. PubMed ID: 32172175
    [No Abstract]   [Full Text] [Related]  

  • 26. Challenges of diabetes management during the COVID-19 pandemic.
    Scott ES; Jenkins AJ; Fulcher GR
    Med J Aust; 2020 Jul; 213(2):56-57.e1. PubMed ID: 32583422
    [No Abstract]   [Full Text] [Related]  

  • 27. New-Onset Diabetes in Covid-19.
    Rubino F; Amiel SA; Zimmet P; Alberti G; Bornstein S; Eckel RH; Mingrone G; Boehm B; Cooper ME; Chai Z; Del Prato S; Ji L; Hopkins D; Herman WH; Khunti K; Mbanya JC; Renard E
    N Engl J Med; 2020 Aug; 383(8):789-790. PubMed ID: 32530585
    [No Abstract]   [Full Text] [Related]  

  • 28. Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemic.
    Chen CF; Chen YT; Chen TH; Chen FY; Yang YP; Wang ML; Huo TI; Chang YL; Charis Tan A; Lin CC
    J Chin Med Assoc; 2020 Sep; 83(9):809-811. PubMed ID: 32433344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.
    Zhou J; Tan J
    Metabolism; 2020 Jun; 107():154216. PubMed ID: 32220612
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.
    Katulanda P; Dissanayake HA; Ranathunga I; Ratnasamy V; Wijewickrama PSA; Yogendranathan N; Gamage KKK; de Silva NL; Sumanatilleke M; Somasundaram NP; Matthews DR
    Diabetologia; 2020 Aug; 63(8):1440-1452. PubMed ID: 32405783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Care for diabetes with COVID-19: Advice from China.
    Wang W; Lu J; Gu W; Zhang Y; Liu J; Ning G
    J Diabetes; 2020 May; 12(5):417-419. PubMed ID: 32285556
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes and COVID-19-the meeting of two pandemics: what are the concerns?
    Coppell KJ; Hall RM; Downie M; Fraser SK; Garrett M; Jefferies CA; Kenealy TW; Milne RE; Orr-Walker BJ; Paul RG; Smallman K; Snell HJ
    N Z Med J; 2020 May; 133(1514):85-87. PubMed ID: 32379745
    [No Abstract]   [Full Text] [Related]  

  • 33. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
    Weis N; Thorsteinsson K; Martinussen C; Madsbad S
    Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes and severity of COVID-19: What is the link?
    Pitocco D; Viti L; Tartaglione L; Di Leo M; Rizzo GE; Manto A; Rizzi A; Caputo S; Pontecorvi A
    Med Hypotheses; 2020 Oct; 143():109923. PubMed ID: 32485315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Issues for the management of people with diabetes and COVID-19 in ICU.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Cardiovasc Diabetol; 2020 Jul; 19(1):114. PubMed ID: 32690029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The COVID-19 Pandemic Revealed the Importance and Shortcomings of Technologies for Diabetes Support.
    Årsand E
    J Diabetes Sci Technol; 2020 Jul; 14(4):712-713. PubMed ID: 32460550
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetes care during the acute phase of infection in ICU patients with specific attention to COVID-19 outbreak.
    Catargi B; Cheisson G; Tauveron I; Jacqueminet S; Benhamou D
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):375-379. PubMed ID: 32620420
    [No Abstract]   [Full Text] [Related]  

  • 38. Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era.
    Aljehani FA; Funke K; Hermayer KL
    Am J Med Sci; 2020 Oct; 360(4):423-426. PubMed ID: 32736827
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID-19 and diabetes mellitus: A need for prudence in elderly patients from a pooled analysis.
    Desai R; Singh S; Parekh T; Sachdeva S; Sachdeva R; Kumar G
    Diabetes Metab Syndr; 2020; 14(4):683-685. PubMed ID: 32438333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is subcutaneous insulin administration adequate for the management of hyperglycemic crisis in COVID-19?
    Permana H; Soetedjo NNM
    Diabetes Metab Syndr; 2020; 14(5):947-948. PubMed ID: 32599534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.